ArticleCell communication and signaling : CCS2026
Inhibition of gasdermin D attenuates neutrophil extracellular trap formation induced by platelet-derived exosome in necrotizing enterocolitis.
Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Necrotizing enterocolitis (NEC) is a critical gastrointestinal disorder observed in neonates, defined by intestinal inflammation and tissue necrosis. This research examines the involvement of gasdermin D (GSDMD) in platelet pyroptosis and its effect on the formation of neutrophil extracellular traps (NETs) in the context of NEC. Clinical data from preterm infants diagnosed with NEC revealed increased inflammatory markers along with signs of platelet pyroptosis. Furthermore, platelet-derived exosomes, identified through transmission electron microscopy and Western blot analysis, were found to facilitate NET formation. In experimental models, the depletion of platelets resulted in decreased levels of NETs and exosome release, while pharmacological inhibition of GSDMD using disulfiram alleviated intestinal injury and enhanced survival rates. Our mechanistic investigations identified mitochondrial reactive oxygen species (ROS) and oxidized mitochondrial DNA (ox-mtDNA) as crucial mediators connecting platelet pyroptosis to NET formation. These findings indicate that targeting GSDMD may offer a promising therapeutic approach for NEC by diminishing excessive NET formation and the resultant inflammatory response.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.